Synapse - Works

Results (5608)

Pharmacodynamic and clinical results from a Phase I/II study of the HSP90 inhibitor onalespib in combination with abiraterone acetate in prostate cancer

Journal Article

Slovin, S.; Hussain, S.; Saad, F.; Garcia, J.; Picus, J.; Ferraldeschi, R.; Crespo, M.; Flohr, P.; Riisnaes, R.; Lin, C.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

The Polycomb Repressor Complex 1 drives double-negative prostate cancer metastasis by coordinating stemness and immune suppression

Journal Article

Su, W.; Han, H. H.; Wang, Y.; Zhang, B.; Zhou, B.; Cheng, Y.; Rumandla, A.; Gurrapu, S.; Chakraborty, G.; Su, J.; more...
Cancer Cell (2019)

Fulltext@MSK | Save

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: Results of >2 years of follow-up

Journal Article

Fradet, Y.; Bellmunt, J.; Vaughn, D. J.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; Choueiri, T. K.; Necchi, A.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry

Journal Article

Francini, E.; Gray, K. P.; Shaw, G. K.; Evan, C. P.; Hamid, A. A.; Perry, C. E.; Kantoff, P. W.; Taplin, M. E.; Sweeney, C. J.
Prostate Cancer and Prostatic Diseases (2019)

Fulltext@MSK | Save

Quality adjusted time without symptoms of disease progression or toxicity (Q-TWIST) of nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) among untreated advanced renal cell carcinoma (ARCC) patients (patients) with intermediate or poor prognostic risk

Meeting Abstract

Shah, R.; Botteman, M.; Kwon, Y.; Gooden, K. M.; Cella, D.; Motzer, R.
Value in Health (2019)

Fulltext@MSK | Save

Impact of FDG PET imaging for expanding patient eligibility and measuring treatment response in a multicenter genome-driven basket trial

Meeting Abstract

Ulaner, G.; Saura, C.; Piha-Paul, S.; Mayer, I.; Quinn, D.; Stone, B.; Mann, G.; Meric-Bernstam, F.; Solit, D.; Hyman, D.
Journal of Nuclear Medicine (2019)

Fulltext@MSK | Save

Results from the OSPREY trial: A Prospective phase 2/3 multi-center study of (18)F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy

Meeting Abstract

Rowe, S.; Gorin, M.; Pienta, K.; Siegel, B.; Carroll, P.; Pouliot, F.; Probst, S.; Saperstein, L.; Preston, M.; Alva, A.; more...
Journal of Nuclear Medicine (2019)

Fulltext@MSK | Save

Pharmacokinetics and biodistribution of a [(86)Zr]Zr-DFO-MSTP2109A anti-STEAP1 antibody in metastatic castration-resistant prostate cancer patients

Journal Article

O'Donoghue, J. A.; Danila, D. C.; Pandit-Taskar, N.; Beylergil, V.; Cheal, S. M.; Fleming, S. E.; Fox, J. J.; Ruan, S.; Zanzonico, P. B.; Ragupathi, G.; more...
Molecular Pharmaceutics (2019)

Fulltext@MSK | Save

Modeling 1-year relapse-free survival after neoadjuvant chemotherapy and radical cystectomy in patients with clinical T2-4N0M0 urothelial bladder carcinoma: Endpoints for phase 2 trials

Journal Article

Bandini, M.; Briganti, A.; Plimack, E. R.; Niegisch, G.; Yu, E. Y.; Bamias, A.; Agarwal, N.; Sridhar, S. S.; Sternberg, C. N.; Vaishampayan, U.; more...
European Urology Oncology (2019)

Fulltext@MSK | Save

Genomic profile of urothelial carcinoma of the upper tract from ureteroscopic biopsy: Feasibility and validation using matched radical nephroureterectomy specimens

Journal Article

Bagrodia, A.; Audenet, F.; Pietzak, E. J.; Kim, K.; Murray, K. S.; Cha, E. K.; Sfakianos, J. P.; Iyer, G.; Singla, N.; Arcila, M.; more...
European Urology Focus (2019)

Fulltext@MSK | Save